Terms: = Endocrine gland cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Clinical Outcome
499 results:
1. Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian cancer.
Lou E; Clemente V; Grube M; Svedbom A; Nelson AC; Blome F; Staebler A; Kommoss S; Bazzaro M
JAMA Netw Open; 2024 Feb; 7(2):e240407. PubMed ID: 38411963
[TBL] [Abstract] [Full Text] [Related]
2. Locally advanced pancreatic cancer: Is surgical palliation associated with improved clinical outcome relative to medical palliation?
Kramer SP; Tonelli C; Luchette FA; Swanson J; Abdelsattar Z; Cohn T; Baker MS
Am J Surg; 2024 Apr; 230():73-77. PubMed ID: 38350746
[TBL] [Abstract] [Full Text] [Related]
3. Adrenal incidentalomas, cortisol secretion and cancer: is there a real crosstalk?
Herrera-Martínez AD; Román ÁR; Corrales EP; Idrobo C; Ramírez PP; Rojas PM; Lázaro CR; Araujo-Castro M
Front Endocrinol (Lausanne); 2023; 14():1335202. PubMed ID: 38264281
[TBL] [Abstract] [Full Text] [Related]
4. Subarachnoid hemorrhage due to pituitary adenoma apoplexy-case report and review of the literature.
Yildiz Y; Lauber A; Char NV; Bozinov O; Neidert MC; Hostettler IC
Neurol Sci; 2024 Mar; 45(3):997-1005. PubMed ID: 37872321
[TBL] [Abstract] [Full Text] [Related]
5. BRAF
Cao J; Chen B; Zhu X; Sun Y; Li X; Zhang W; Wang X
Endocrine; 2024 Apr; 84(1):160-170. PubMed ID: 37851243
[TBL] [Abstract] [Full Text] [Related]
6. Optimal Follow-up of Incidental Pancreatic Cystic Lesions without Worrisome Features: clinical outcome after Long-term Follow-up.
Ahn DW; Lee SH; Choi JH; Cho IR; Jang DK; Paik WH; Jeong JB; Ryu JK; Kim YT
Gut Liver; 2024 Mar; 18(2):328-337. PubMed ID: 37840221
[TBL] [Abstract] [Full Text] [Related]
7. Response of Locally Advanced Pancreatic cancer to Intratumoral Injection of Large Surface Area Microparticle Paclitaxel: Initial Report of Safety and clinical outcome.
Sharma NR; Lo SK; Hendifar A; Othman MO; Patel K; Mendoza-Ladd A; Verco S; Maulhardt HA; Verco J; Wendt A; Marin A; Schmidt CM; diZerega G
Pancreas; 2023 Mar; 52(3):e179-e187. PubMed ID: 37782888
[TBL] [Abstract] [Full Text] [Related]
8. Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
Neyrand S; Trecourt A; Lopez J; Just PA; Descotes F; Borson-Chazot F; Ray-Coquard I; Decaussin-Petrucci M; Devouassoux-Shisheboran M
Histopathology; 2024 Jan; 84(2):291-300. PubMed ID: 37771077
[TBL] [Abstract] [Full Text] [Related]
9. The impact of microscopic extrathyroidal extension on the clinical outcome of classic subtype papillary thyroid microcarcinoma: a multicenter study.
Zuhur SS; Aggul H; Avci U; Erol S; Tuna MM; Uysal S; Akbaba G; Kilinc F; Catak M; Tekin S; Ozturk BO; Yavuz HC; Kadioglu P; Cinar N; Bayraktaroglu T; Topcu B; Altuntas Y; Elbuken G
Endocrine; 2024 Mar; 83(3):700-707. PubMed ID: 37736822
[TBL] [Abstract] [Full Text] [Related]
10. Real time
Kim DW; Beato F; Kim Y; Tassielli AF; Dai R; Denbo JW; Hodul PJ; Malafa MP; Fleming JB
Oncotarget; 2023 Sep; 14():811-818. PubMed ID: 37713330
[TBL] [Abstract] [Full Text] [Related]
11. Efficacy and safety of microwave ablation for the treatment of multifocal versus unifocal T1N0M0 papillary thyroid carcinoma: a propensity-matched multicentre retrospective study.
Zhao ZL; Dong G; Wang SR; Liu Y; He JF; Shi LL; Guo JQ; Wang ZH; Cong ZB; Liu LH; Yang BB; Qu CP; Wei Y; Peng LL; Li Y; Lu NC; Wu J; Yu MA
Eur Radiol; 2023 Dec; 33(12):8727-8735. PubMed ID: 37466709
[TBL] [Abstract] [Full Text] [Related]
12. The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas-New Potential Therapeutic Approach-A Systematic Review.
Derwich A; Sykutera M; Bromińska B; Rubiś B; Ruchała M; Sawicka-Gutaj N
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446128
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic value of perioperative serum low-density lipoprotein cholesterol level for postoperative prognosis of pancreatic cancer: a retrospective study.
Wang H; Li Y; Huang J; Ma Y; Lyu S; Lang R
Lipids Health Dis; 2023 Jun; 22(1):88. PubMed ID: 37391827
[TBL] [Abstract] [Full Text] [Related]
14. Two- and three-dimensional endoscopic endonasal surgery of large and giant pituitary adenomas-outcome analysis of a series of 62 patients from a single pituitary center.
Loeschner D; Enciu A; Kellner G; Meyer A; Wallaschofski H; McLean ACL; Gerlach R
Neurosurg Rev; 2023 Jun; 46(1):150. PubMed ID: 37358696
[TBL] [Abstract] [Full Text] [Related]
15. Incidentally detected 18 F-FDG PET-CT-avid thyroid nodules in patients with advanced malignancy: long-term oncological outcomes from a single-centre retrospective cohort.
Owens C; Fitzhugh A; Harrington K; Paleri V; Sharma B; Shur J; Ap Dafydd D
Nucl Med Commun; 2023 Sep; 44(9):810-815. PubMed ID: 37272278
[TBL] [Abstract] [Full Text] [Related]
16. FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by Morphology.
Wessman S; Fuentes BB; Severin-Karlsson J; Westbom-Fremer S; Nistér M; Kokaraki G; Petta TB; Haglund F; Carlson JW
Int J Gynecol Pathol; 2024 Jan; 43(1):78-89. PubMed ID: 37255476
[TBL] [Abstract] [Full Text] [Related]
17. clinical and imaging findings for the evaluation of large Rathke's cleft cysts and cystic craniopharyngiomas.
Yang CH; Wu CH; Lin TM; Chen ST; Tai WA; Yu KW; Luo CB; Lirng JF; Chang FC
Pituitary; 2023 Aug; 26(4):393-401. PubMed ID: 37227614
[TBL] [Abstract] [Full Text] [Related]
18. Recurrence and mortality rate in an Italian multi-center case series of parathyroid atypical adenomas and carcinomas.
Barale M; Nervo A; Craparo A; Pusterla A; Retta F; Maiorino F; Castellano E; Piovesan A; Gianotti L; Borretta G; Procopio M; Arvat E
Front Endocrinol (Lausanne); 2023; 14():1158474. PubMed ID: 37223026
[TBL] [Abstract] [Full Text] [Related]
19. KRAS mutation in primary ovarian serous borderline tumors correlates with tumor recurrence.
McHenry A; Rottmann DA; Buza N; Hui P
Virchows Arch; 2023 Jul; 483(1):71-79. PubMed ID: 37219599
[TBL] [Abstract] [Full Text] [Related]
20. Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer.
Inkoom A; Ndemazie NB; Smith T; Frimpong E; Bulusu R; Poku R; Zhu X; Han B; Trevino J; Agyare E
BMC Cancer; 2023 May; 23(1):435. PubMed ID: 37179357
[TBL] [Abstract] [Full Text] [Related]
[Next]
